Results 221 to 230 of about 3,520,446 (404)

Budget Impact Analysis of the Balanced Opioid Initiative: A Cluster Randomized Trial Aimed at Deprescribing Opioids for Chronic Pain in Primary Care Settings. [PDF]

Ann Fam Med
Quanbeck A, Li X, Cohen A, Butzine E, Brown RT.   +4 more
europepmc   +1 more source

Analysis of The Effect of LM Gold Sell Prices on Sales with Distribution Costs and Promotion Cost as Mediation Variables in PT.ANTAM Tbk UBPP LM

, 2018
Ade Prasetyo
openalex   +1 more source

​Did a Non‐Medical Biosimilar Switching Policy Cause an Increase in Non‐Biologic/Biosimilar Health Care Resource Utilization or Cost in Patients With Inflammatory Arthritis?

Arthritis Care &Research, EarlyView.
Objective This study aimed to evaluate the impact of a series of policies that mandated switching patients with inflammatory arthritis (IA) from an originator biologic to a biosimilar in British Columbia, Canada, on health care resource use and cost.
HaoHung Dang, Sandra Blitz, Nick Bansback, Michael Law, Mark Harrison   +4 more
wiley   +1 more source

Provider-perspective cost analysis of comprehensive pediatric cataract management in a low-income setting. [PDF]

Sci Rep
Poschkamp B, Duerksen R, Jaspe MM, Mukwanseke E, Stahl A, Guthoff R, Moanda A, Steinau EC, Ngoy JK, Fleßa S.   +9 more
europepmc   +1 more source

Study of a comparative analysis model of environmental and economic costs on a façade based on the life cycle approach = Estudio de modelo de análisis comparativo de costes ambientales y económicos de una fachada basado en el enfoque del ciclo de vida

, 2017
Nuria García Horcajo
openalex   +2 more sources

Development of a cost analysis spreadsheet for calculating the costs to raise a replacement dairy heifer.

Journal of Dairy Science, 2000
M. T. Gabler, P. R. Tozer, A. Heinrichs
semanticscholar   +1 more source

A Scoping Review on Artificial Intelligence–Supported Interventions for Nonpharmacologic Management of Chronic Rheumatic Diseases

Arthritis Care &Research, EarlyView.
This review summarizes artificial intelligence (AI)‐supported nonpharmacological interventions for adults with chronic rheumatic diseases, detailing their components, purpose, and current evidence base. We searched Embase, PubMed, Cochrane, and Scopus databases for studies describing AI‐supported interventions for adults with chronic rheumatic diseases.
Nirali Shah, Alexis Castellanos, Yen Chen, John Piette, Amy Bucher, Susan Murphy   +5 more
wiley   +1 more source

A cost-effectiveness analysis comparing pembrolizumab combined with chemotherapy versus chemotherapy alone for advanced biliary tract cancer: US and China perspectives. [PDF]

PLoS One
Zhang C, Liang H, Qin Y, Tan X, Su X, Tian X, Nong Y.   +6 more
europepmc   +1 more source

Assessment of the driving factors of CO2 mitigation costs of household biogas systems in China: A LMDI decomposition with cost analysis model

, 2021
Weishi Zhang, Ying Xu, Can Wang, David G. Streets   +3 more
openalex   +2 more sources

Cost-effectiveness and cost-benefit analysis [PDF]

, 2010
Robert A. Rosenheck, Douglas L. Leslie
openaire   +1 more source